Track topics on Twitter Track topics that are important to you
Atomwise, a San Francisco startup that’s using artificial intelligence to hunt for compounds that could make effective new drugs, announced today that it raised a $45 million Series A round. The sma...
Atomwise, a San Francisco, CA-based company that develops artificial intelligence systems for drug discovery has raised $45 million in Series A funding led by Monsanto Growth Ventures, B Capital Group...
Press:For AtomwiseEmily Rose, (212) 738-6066Emily.Rose@edelman.com Read more...
Atomwise Inc. today announced it has raised $45 million of growth funding, led by Monsanto Growth Ventures, DCVC (Data Collective), and B Capital Group, in support of its mission ...
Atomwise uses artificial intelligence to help discover new medicines and agricultural compounds. Its groundbreaking AtomNet technology reasons like a human chemist, using powerful...
We have published hundreds of Atomwise Inc. news stories on BioPortfolio along with dozens of Atomwise Inc. Clinical Trials and PubMed Articles about Atomwise Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Atomwise Inc. Companies in our database. You can also find out about relevant Atomwise Inc. Drugs and Medications on this site too.
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...